Treatment of cells with antisense miR-21 was shown to decrease the expression of epidermal growth factor receptor (EGFR) and activate AKT, cyclin D, and BCL-2, which suggests that miR-21 may be a novel therapeutic target for malignant gliomas (Zhou et al., 2010a). This evidence concerns the gene EGFR and malignant glioma.